Lite Strategy Inc (LITS) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Lite Strategy Inc   (NASDAQ: LITS)


Lite Strategy Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lite Strategy Inc's ROI in the fourth quarter of 2026?
Lite Strategy Inc recorded a cumulative net loss of $-71 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -125.01%.

Within the Healthcare sector 662 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 4109, from total ROI ranking in the third quarter of 2026 at 4699.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
Y / Y Investment Change TTM 141.24 % 83.75 % 8.59 % -17.39 % -67.21 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 42 57 17 112 17
Return On Investment (TTM) -125.01 % -119.86 % -95.85 % -25.48 % -67.59 %
LITS's Overall Ranking # 4109 # 4699 # 3524 # 4038 # 4314
Seq. Investment Change TTM 12.17 % 22.51 % -8.85 % 92.6 % -14.57 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -71 -61 -40 -12 -16




Return On Investment LITS's Ranking
Within: No.
Industry # 297
Sector # 663
Overall # 4109

Return On Investment Statistics
High Average Low
38.41 %
-49.38 %
-256.82 %
(Sep 30 2023)   (Sep 30 2012)







Financial Statements
Lite Strategy Inc's IV. Quarter Investments $ 42 Millions LITS's Balance sheet
Lite Strategy Inc's IV. Quarter Income $ -13 Millions Quarterly LITS's Income Statement
LITS's Income by Division See LITS's Income by Division


LITS Annual Return On Investment (Jun 30 2026)
2026
(Jun 30 2025)
2025
(Jun 30 2024)
2024
(Jun 30 2023)
2023
(Jun 30 2022)
2022
Total Investments in Millions 42 17 33 100 153
Y / Y Investment Growth 145.84 % -48.73 % -67.13 % -34.5 % -0.32 %
Net Income in Millions -71 -16 18 -32 -54
Y / Y Net Income Growth - - - - -
Annual Return On Investment -170.94 % -94.18 % 53.84 % -31.69 % -35.5 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LITS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LITS's Competitors
Subscribers only: Roi for Lite Strategy Inc's Suppliers
Subscribers only: Return On Investment for LITS's Customers

Other Ratios
LITS's Roa LITS's Inventory Turnover Ratio LITS's Growth Rates LITS's Dividend Statistics
LITS's Profitability Ratios LITS's Asset Turnover Ratio LITS's Dividend Growth
LITS's Roe LITS's Valuation Ratios LITS's Financial Strength Ratios LITS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-29T02:58:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.